© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
January 22, 2021
These findings underscore the importance of safely implementing new marijuana legislation across the US.
January 19, 2021
Dr. Matthew Brams presented new data showing the efficacy of CTx-1301 for ADHD.
A high fasting insulin level trajectory was associated with psychosis, while puberty-onset BMI increase was linked to depression.
January 18, 2021
CTx-1301's formulation enables 3 different doses within 1 pill for ADHD.
Such scores could provide insight into the significant comorbidity rate of ADHD and other youth mood and emotional dysregulation issues.
January 17, 2021
Randomized controlled trials are needed to evaluate their efficacy in comparison with in-person group meetings.
Investigators have observed a development-related shift in risks from teenaged ADHD and alcohol use risks in the patients' 30s.
A pair of researchers present plans to improve collaboration with other professionals in ADHD.
The likelihood of smoking addiction is associated with traits also closely associated with worsened ADHD.
An ADHD coach can work on more goal-based plans for individuals with ADHD.